1-216073261-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong
The NM_206933.4(USH2A):c.5612G>A(p.Gly1871Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000266 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G1871G) has been classified as Likely benign.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| USH2A | NM_206933.4 | c.5612G>A | p.Gly1871Asp | missense_variant | Exon 28 of 72 | ENST00000307340.8 | NP_996816.3 | |
| USH2A-AS2 | NR_125992.1 | n.136+661C>T | intron_variant | Intron 1 of 2 | ||||
| USH2A-AS2 | NR_125993.1 | n.136+661C>T | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 156AN: 152040Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000351 AC: 88AN: 250594 AF XY: 0.000221 show subpopulations
GnomAD4 exome AF: 0.000186 AC: 272AN: 1461626Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 127AN XY: 727116 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00103 AC: 157AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.00102 AC XY: 76AN XY: 74380 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
- -
Observed with a second USH2A variant (phase unknown) in a patient with retinitis pigmentosa and in an unrelated patient with hearing loss in published literature (PMID: 30902645, 34837038); Observed in the heterozygous state with no other variant in the USH2A gene in a patient with retinitis pigmentosa in published literature; patient also harbored a variant in the EYS gene (PMID: 26806561); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34837038, 34426522, 32483926, 26806561, 30902645, 33623043) -
- -
- -
not specified Uncertain:1Benign:1
p.Gly1871Asp in exon 28 of USH2A: This variant is not expected to have clinical significance because it has been identified in 0.3% (36/10338) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs140895792). -
Variant summary: USH2A c.5612G>A (p.Gly1871Asp) results in a non-conservative amino acid change located in the Laminin G (IPR001791) and Fibronectin type III (IPR003961) domains of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00035 in 250594 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in USH2A causing Usher Syndrome (0.00035 vs 0.011), allowing no conclusion about variant significance. c.5612G>A has been reported in the literature in individuals affected with hearing loss and retinitis pigmentosa (examples: Perez-Carro_2015, Martin-Merida_2019, Adeyemo_2022). These reports do not provide unequivocal conclusions about association of the variant with Usher Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34837038, 33623043, 30902645, 26806561). ClinVar contains an entry for this variant (Variation ID: 48537). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Retinitis pigmentosa 39 Pathogenic:1
- -
Childhood onset hearing loss Uncertain:1
PP3 (non REVEL) / Modifications from PMID: 30311386 for classification: The genetic causes of hearing loss have not yet been well characterized in the Yoruba population, and the information regarding variant MAF in this population is still limited, so we did not exclude any variant based on their "high" MAF. PP3 criteria was applied even if the REVEL score was below 0.7, if at least two of the pathogenicity prediction algorithms used predicted that the variant was damaging or likely damaging. -
Usher syndrome type 2A Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at